Menu Philippe 4
4 · SOPHiA GENETICS SA · Filed Jul 7, 2026
Research Summary
AI-generated summary of this filing
SOPHiA GENETICS (SOPH) CMO Philippe Menu Sells 7,393 Shares
What Happened Philippe Menu, Chief Medical Officer of SOPHiA GENETICS SA (SOPH), sold 7,393 shares on 2026-07-06 in open-market transactions. The filing reports a weighted-average price of $5.16 per share (range $4.97–$5.44), for total proceeds of approximately $38,156. This was a sale (routine cash outflow), not a purchase.
Key Details
- Transaction date: 2026-07-06; Form 4 filed: 2026-07-07 (appears timely).
- Reported price: weighted average $5.16; individual trades ranged $4.97–$5.44.
- Shares sold: 7,393; proceeds ≈ $38,156.
- Shares owned after transaction: Not disclosed in this filing.
- Footnotes: Sale executed pursuant to a pre-established Rule 10b5-1(c) trading plan and was done to satisfy tax withholding obligations arising from restricted stock units that vested on July 2 and July 3, 2026. The price shown is a weighted average; the filer can provide per-trade prices on request.
Context Sales to cover tax withholding on RSU vesting are common and are generally considered routine rather than a signal of changed insider sentiment. The transaction was executed under a 10b5-1 plan, meaning it was pre-scheduled and non-discretionary.
Insider Transaction Report
Form 4
Menu Philippe
Chief Medical Officer
Transactions
- Sale
Ordinary Shares
[F1][F2]2026-07-06$5.16/sh−7,393$38,156→ 233,387 total
Footnotes (2)
- [F1]Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on July 2 and July 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
- [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $4.97 to $5.44, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Signature
/s/ Elimara Brunetto as Attorney-in-fact for Philippe Menu|2026-07-07